← USPTO Patent Grants

Nucleotide analogues

Grant US12582656B2 Kind: B2 Mar 24, 2026

Assignee

R.G.C.C. Holdings AG

Inventors

Ioannis Papasotiriou

Abstract

A compound according to the formula I for use in the treatment of coronavirus infection and/or a respiratory disease caused by a coronavirus, wherein R1 is chosen from alkoxy groups such as for example methoxy or ethoxy, hydroxyl group, and phosphate group,wherein R2 is a group chosen from halogen and/or hydrogen,wherein Y is a nucleic base, preferably a purine or pyrimidine.

CPC Classifications

A61K 31/517 A61P 31/14 A61P 11/00

Filing Date

2021-03-23

Application No.

17914634

Claims

6

View original document →